
Ahmed Magdy Rabea/LinkedIn
Apr 12, 2025, 16:05
Ahmed Magdy Rabea: It was a pleasure to give a talk about the AEGEAN trial at ISCO meeting 2025
Ahmed Magdy Rabea, Assistant Professor at National Cancer Institute, shared a post on LinkedIn:
“It was my pleasure to give a comprehensive talk about the AEGEAN trial using Durvalumab in the perioperative setting in NSCLC during the prestigious ISCO meeting 2025. Thank you AstraZeneca for inviting me to be your speaker.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 12, 2025, 19:25
Apr 12, 2025, 19:14
Apr 12, 2025, 19:10
Apr 12, 2025, 18:52
Apr 12, 2025, 18:48